Divarasib plus cetuximab in KRAS G12C-positive colorectal cancer: a phase 1b trial
Protocol at a Glance: Loading phase (weeks 1-4): 5mg per week Maintenance (weeks 5-8): 2.5mg per week Frequency: Split into 2 doses (e.g., Monday/Thursday) Method: SubQ injection anywhere (abdomen common) Duration: 8-12 weeks total Cost: $150-200 for 8-week cycle Results Timeline: Week 2-3: Reduced inflammation, better mobility Week 4-6: Significant visible healing Week 8-12: Near-complete recovery for most injuries Unlike BPC-157's quick response, TB-500 takes longer to show results, but the systemic benefits make it worth the wait
[10] [11] Symptoms warranting thyroid function assessment include unexplained fatigue, weight changes beyond those expected from GLP-1 therapy, changes in heart rate, mood alterations, temperature intolerance, or changes in bowel habits
And they don't rebuild your capacity for joy which requires time, new pathways, and the willingness to feel everything , including the hard stuff
